Pfizer Nabs 9th Circ. Victory In Zoloft False-Ad Suit

By Kat Sieniuc (November 9, 2016, 7:13 PM EST) -- Pfizer Inc. defeated class allegations Wednesday that it greatly exaggerated the efficacy of its antidepressant Zoloft, after the Ninth Circuit agreed that the consumer waited too long to lodge her claims.

California's U.S. District Judge Lucy H. Koh had dismissed Laura Plumlee's claims with prejudice in September 2014, saying they were time-barred under the applicable three- and four-year statutes of limitations.

Plumlee had last purchased Zoloft or its generic equivalent in 2008, and by the time she brought her case in 2013, she had exceeded by at least seven months the limitations periods under the various California consumer protection laws she...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!